Beta© 2026 Adaptrex, LLC
Beta© 2026 Adaptrex, LLC
Federal grant · cooperative agreement (b)
Purpose: There Currently Exists a Need in the Biopharmaceutical Industry for a Sensor to Accurately Detect Cell and Metabolite Properties in Real Time. Researchers in This Phase I Propose to Develop an Artificial Intelligence (AI) Deep Learning System That Seeks to Fill This Need.activities to Be Performed: Activities to Be Performed Will Include Conducting Experiments, Calibrations, Measurements, and Tests to Prove the Feasibility of the Research.expected Outcomes: This Research Will Advance the Safe and Efficient Adoption of Contactless (AI) Deep Learning Sensing Systems for Control of a Variety of Bioreactor Environments.intended Beneficiaries: This Research Will Benefit the Biopharmaceutical Industry and the Near Infrared (NIR) and Raman Spectroscopy Market.subrecipient Activities: the Recipient Plans to Subaward Funds for Development of Algorithms, Data Analysis and Related Experiments.
Committed
$99,759
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…